ENTRY       D11991                      Drug
NAME        Zenocutuzumab (USAN/INN)
FORMULA     C6479H9971N1725O2027S45
EXACT_MASS  145812.7612
MOL_WEIGHT  145902.7613
SEQUENCE    (Heavy chain A)
            QVQLVQSGAE VKKPGASVKV SCKASGYTFT GYYMHWVRQA PGQGLEWMGW INPNSGGTNY
            AQKFQGRVTM TRDTSISTAY MELSRLRSDD TAVYYCARDH GSRHFWSYWG FDYWGQGTLV
            TVSSASTKGP SVFPLAPSSK STSGGTAALG CLVKDYFPEP VTVSWNSGAL TSGVHTFPAV
            LQSSGLYSLS SVVTVPSSSL GTQTYICNVN HKPSNTKVDK RVEPKSCDKT HTCPPCPAPE
            LLGGPSVFLF PPKPKDTLMI SRTPEVTCVV VDVSHEDPEV KFNWYVDGVE VHNAKTKPRE
            EQYNSTYRVV SVLTVLHQDW LNGKEYKCKV SNKALPAPIE KTISKAKGQP REPQVYTKPP
            SREEMTKNQV SLKCLVKGFY PSDIAVEWES NGQPENNYKT TPPVLDSDGS FFLYSKLTVD
            KSRWQQGNVF SCSVMHEALH NHYTQKSLS SPG
            (Heavy chain B)
            QVQLVQSGAE VKKPGASVKL SCKASGYTFT AYYINWVRQA PGQGLEWIGR IYPGSGYTSY
            AQKFQGRATL TADESTSTAY MELSSLRSED TAVYFCARPP VYYDSAWFAY WGQGTLVTVS
            SASTKGPSVF PLAPSSKSTS GGTAALGCLV KDYFPEPVTV SWNSGALTSG VHTFPAVLQS
            SGLYSLSSVV TVPSSSLGTQ TYICNVNHKP SNTKVDKRVE PKSCDKTHTC PPCPAPELLG
            GPSVFLFPPK PKDTLMISRT PEVTCVVVDV SHEDPEVKFN WYVDGVEVHN AKTKPREEQY
            NSTYRVVSVL TVLHQDWLNG KEYKCKVSNK ALPAPIEKTI SKAKGQPREP QVYTDPPSRE
            EMTKNQVSLT CEVKGFYPSD IAVEWESNGQ PENNYKTTPP VLDSDGSFFL YSKLTVDKSR
            WQQGNVFSCS VMHEALHNHY TQKSLSLSPG
            (Light chain)
            DIQMTQSPSS LSASVGDRVT ITCRASQSIS SYLNWYQQKP GKAPKLLIYA ASSLQSGVPS
            RFSGSGSGTD FTLTISSLQP EDFATYYCQQ SYSTPPTFGQ GTKVEIKRTV AAPSVFIFPP
            SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT
            LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC
            (Disulfide bridge: A22-A96, A151-A207, A227-B214, A233-B230, A236-B233, A268-A328, A374-A432, B22-B96, B148-B204, B224-L'214, B265-B325, B371-B429, L23-L88, L134-L194, L'23-L'88, L'134-L'194)
  TYPE      Peptide
EFFICACY    Antineoplastic, Anti-EGFR antibody
  TYPE      Monoclonal antibody, bispecific antibody
TARGET      ERBB2 (HER2, CD340) [HSA:2064] [KO:K05083]
            ERBB3 (HER3) [HSA:2065] [KO:K05084]
  PATHWAY   hsa04012(2064+2065)  ErbB signaling pathway
            hsa04151(2064+2065)  PI3K-Akt signaling pathway
BRITE       Target-based classification of drugs [BR:br08310]
             Protein kinases
              Receptor tyrosine kinases (RTK)
               EGFR family
                ERBB2 (HER2, CD340)
                 D11991  Zenocutuzumab (USAN/INN)
                ERBB3 (HER3)
                 D11991  Zenocutuzumab (USAN/INN)
DBLINKS     CAS: 1969309-56-5
///
